Bio Path | BPTH - Umsatzerlöse





Der Umsatz Veränderung Datum
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Baxter International USD 2.7B 270M 2026-03
Bio Path 0 0 2025-03
Cipla INR 65.41B 9.77B 2026-03
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 6.35M 60.98M 2026-03
CSL USD 8.33B 4.79B 2025-12
Grifols EUR 2B 306.7M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12